Understanding Elsberg Syndrome: A Rare Neurological Complication of HSV-2

Elsberg syndrome is a rare form of acute cauda equina syndrome characterized by radiculitis and urinary retention, often triggered by a primary Herpes Simplex Virus type 2 (HSV-2) infection. While typically associated with visible spinal cord inflammation on imaging, clinical cases—including those documented in the Cureus Journal of Medical Science—demonstrate that patients may present with severe neurological symptoms despite normal spinal MRI findings. Prompt identification and antiviral intervention are essential to preventing long-term bladder and bowel dysfunction.

Clinical Presentation and Pathophysiology

The syndrome primarily manifests as a sudden onset of urinary retention, constipation, and sensory disturbances in the “saddle” region (the perineum, buttocks, and inner thighs). According to the National Institutes of Health (NIH), these symptoms arise from the inflammation of the lumbosacral nerve roots. While HSV-2 is the most common viral trigger, the condition is categorized as a post-infectious or parainfectious inflammatory response.

The pathophysiology involves the virus traveling to the sacral ganglia during a primary infection. Even after the initial skin lesions or genital sores heal, the viral reactivation or the associated inflammatory response can affect the nerve roots responsible for autonomic and motor control of the pelvic organs. This explains why patients may develop neurological deficits even when systemic viral markers appear to be in remission.

Diagnostic Challenges with Normal Imaging

A significant diagnostic hurdle in Elsberg syndrome is that spinal magnetic resonance imaging (MRI) is frequently normal in the early stages. The Clinical Infectious Diseases journal notes that clinicians often rely on a combination of clinical history and cerebrospinal fluid (CSF) analysis to confirm the diagnosis.

In cases where MRI scans show no structural abnormalities, such as disc herniation or spinal stenosis, physicians must maintain a high index of suspicion for viral radiculitis. Diagnostic confirmation typically requires:

• CSF Analysis: Detecting pleocytosis (elevated white blood cell count) and elevated protein levels.
• PCR Testing: Identifying HSV-2 DNA within the spinal fluid.
• Clinical Assessment: Evaluating for the classic triad of sacral radiculitis, urinary retention, and genital herpes lesions.

Treatment and Prognosis

The standard of care for Elsberg syndrome secondary to HSV-2 is the administration of intravenous acyclovir. Early initiation of antiviral therapy is critical, as it can reduce the duration of nerve inflammation and improve the likelihood of a full recovery of bladder function. According to guidance from the Centers for Disease Control and Prevention (CDC) regarding herpes infections, while antiviral medication does not cure the virus, it effectively manages the inflammatory sequelae that lead to neurological complications.

Most patients experience a gradual improvement in neurological symptoms over weeks to months. However, some individuals may require long-term intermittent catheterization if urinary retention persists. Because the condition is immune-mediated, some clinicians may consider adjunctive therapies, such as corticosteroids, though their use remains a subject of ongoing clinical debate and case-by-case evaluation.

Key Considerations for Patients

If you experience sudden urinary retention, lower back pain, or numbness in the pelvic area following a diagnosis of genital herpes, seek immediate medical attention. Elsberg syndrome is a medical emergency that requires specialized neurological and urological evaluation to prevent permanent nerve damage.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult a board-certified physician for concerns regarding neurological or infectious disease symptoms.